PHACTR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.509000E-01
Normal-vs-Stage2
6.377200E-01
Normal-vs-Stage3
1.459980E-01
Normal-vs-Stage4
6.013400E-01
Stage1-vs-Stage2
9.628400E-01
Stage1-vs-Stage3
3.821600E-01
Stage1-vs-Stage4
3.338200E-01
Stage2-vs-Stage3
3.102800E-01
Stage2-vs-Stage4
2.952600E-01
Stage3-vs-Stage4
3.761700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.506800E-01
Normal-vs-AfricanAmerican
6.388400E-01
Normal-vs-Asian
4.933000E-01
Caucasian-vs-AfricanAmerican
6.595700E-02
Caucasian-vs-Asian
6.391400E-01
AfricanAmerican-vs-Asian
1.591970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.653600E-01
Normal-vs-Female
6.835600E-01
Male-vs-Female
5.307400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.950800E-01
Normal-vs-Age(41-60Yrs)
8.417800E-01
Normal-vs-Age(61-80Yrs)
5.264200E-01
Normal-vs-Age(81-100Yrs)
4.399000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.725200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.996000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.209600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.797400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.642400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.304200E-01
Normal-vs-Daily Drinker
2.157800E-01
Normal-vs-Weekly Drinker
7.840000E-01
Normal-vs-Occasional Drinker
5.789000E-01
Normal-vs-Social Drinker
9.082000E-01
Non Drinker-vs-Daily Drinker
6.471200E-01
Non Drinker-vs-Weekly Drinker
1.617220E-01
Non Drinker-vs-Occasional Drinker
3.719200E-01
Non Drinker-vs-Social Drinker
2.657800E-01
Daily Drinker-vs-Weekly Drinker
1.230750E-01
Daily Drinker-vs-Occasional Drinker
2.570000E-01
Daily Drinker-vs-Social Drinker
1.910230E-01
Weekly Drinker-vs-Occasional Drinker
6.468400E-01
Weekly Drinker-vs-Social Drinker
8.843600E-01
Occasional Drinker-vs-Social Drinker
5.903000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.242400E-01
Normal-vs-Grade 2
6.796000E-02
Normal-vs-Grade 3
1.012150E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.738220E-01
Grade 1-vs-Grade 3
8.102600E-01
Grade 1-vs-Grade 4
2.242400E-01
Grade 2-vs-Grade 3
1.672770E-01
Grade 2-vs-Grade 4
6.796000E-02
Grade 3-vs-Grade 4
1.012150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.951000E-01
Normal-vs-NonDiabetic
4.968600E-01
Diabetic-vs-NonDiabetic
6.825000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.149800E-01
Normal-vs-NoPancreatitis
5.030600E-01
Pancreatitis-vs-NoPancreatitis
5.733200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.428800E-01
Normal-vs-N1
6.230400E-01
N0-vs-N1
8.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.981400E-01
Normal-vs-TP53-NonMutant
8.368000E-01
TP53-Mutant-vs-TP53-NonMutant
3.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
